نتائج البحث

Comparing Costs and Healthcare Resource Utilization (HCRU) Using LAMA versus LABA/ICS at Treatment Initiation for COPD: Findings from CITRUS (Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea) Study

• Authors : Choi KY; Kim HI; Rhee CK

Subjects: chronic obstructive pulmonary disease; inhaled corticosteroids; long-acting beta-2 agonists

• Source: International Journal of COPD, Vol 19, Pp 1661-1671 (2024)

تفاصيل العنوان

Comparing Costs and Healthcare Resource Utilization (HCRU) Using LAMA versus LABA/ICS at Treatment Initiation for COPD: Findings from CITRUS (Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea) Study

• Authors : Choi,Kwang Yong; Kim,Hwan Il; Rhee,Chin

Subjects: International Journal of Chronic Obstructive Pulmonary Disease; Original Research; info:eu-repo/semantics/article

تفاصيل العنوان

Healthcare Resource Utilization (HCRU) and Direct Medical Costs Associated with Long COVID or Post-COVID-19 Conditions: Findings from a Literature Review

• Authors : Elżbieta Łukomska; Krzysztof Kloc; Malwina Kowalska

Subjects: SARS-CoV-2; COVID-19; long COVID

• Source: Journal of Market Access & Health Policy, Vol 13, Iss 1, p 7 (2025)

تفاصيل العنوان

Clinical Outcomes and Healthcare Cost and Resource Utilization (HCRU) in Patients With Type 2 Diabetes and Cardiovascular Disease on 2nd Line Empagliflozin Versus 2nd Line Sulfonylureas

• Source: Clinical and Economic Impact of 2nd Line Initiation of Empagliflozin After Metformin, as Compared to 2nd Line Initiation of Sulfonylurea After Metformin in Patients With Type 2 Diabetes and

تفاصيل العنوان

Clinical burden and healthcare resource utilization associated with achondroplasia: a real-world observational, retrospective cohort study.

• Authors : Abraham, Pranav¹ (AUTHOR) ; Miles, Gandarvaka¹ (AUTHOR); Petruski-Ivleva, Natalia¹ (AUTHOR)

• Source: Orphanet Journal of Rare Diseases. 11/5/2025, Vol. 20 Issue 1, p1-10. 10p.

تفاصيل العنوان

Real-World Osteoporosis Treatment Gap and Costs in Spain: Data from Women with a First Fragility Fracture or Diagnosis of Postmenopausal Osteoporosis

• Authors : Antoni Sicras-Mainar; Francesc Sorio-Vilela; Marta Sacrest-Soy

Subjects: Postmenopausal osteoporosis; Real-world; RC925-935

• Source: Rheumatol TherRheumatology and Therapy, Vol 12, Iss 2, Pp 315-335 (2025)

تفاصيل العنوان

P781: CLINICAL OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION (HCRU) IN PATIENTS WITH LR-MDS REINITIATING ESAS FOLLOWING PREVIOUS ESA TREATMENT

• Authors : G. Garcia-Manero; R. K. Matsuno; A. McBride

Subjects: Diseases of the blood and blood-forming organs; RC633-647.5

• Source: HemaSphere, Vol 6, Pp 676-677 (2022)

تفاصيل العنوان

Healthcare Resource Utilisation and Costs in Patients with Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Analysis of German Insurance Claims Data

• Authors : Paul Dolin; Anat Shavit; Jennifer Rowell

Subjects: AOK plus; Economic burden; Eosinophilic granulomatosis with polyangiitis

• Source: Rheumatology and Therapy, Vol 12, Iss 6, Pp 1137-1157 (2025)

تفاصيل العنوان

Chemotherapy-induced febrile neutropenia (FN): healthcare resource utilization (HCRU) and costs in commercially insured patients in the US

• Authors : Flanigan, Jeanine A.; Yasuda, Marie; Chen, Chi-Chang

• Source: Supportive Care in Cancer ; volume 32, issue 6 ; ISSN 0941-4355 1433-7339

تفاصيل العنوان

94P Real-world characteristics, treatments and healthcare recourse utilization (HCRU) of patients (pts) with advanced/metastatic non-small cell lung cancer (mNSCLC) managed with first-line (1L) immuno-oncology (IO) strategies in Greece: The IO-HORIZON study

• Authors : Ziogas, D.; Linardou, H.; Charpidou, A.

• Source: Immuno-Oncology and Technology ; volume 24, page 100837 ; ISSN 2590-0188

تفاصيل العنوان